T-Ray Science Inc.
In Vancouver, British Columbia, Canada, T-Ray Science Inc. has
announced milestones toward the commercialization of its detection technology for
skin cancer. The medical device company has signed a research agreement with the
Skin Care Centre at Vancouver General Hospital and the University of British Columbia,
received a Health Canada ruling that will simplify the approval process for the
Verisante Aura multimodality imaging and spectroscopy system for skin cancer detection,
and signed a lease for a manufacturing facility in Richmond, British Columbia. The
announcements indicate progress toward bringing to market the benefits of the Aura
system, which include better patient outcomes, system-wide cost savings and immediate
diagnoses.
LATEST NEWS